Article

Epitranscriptome Changes in Neurodegenerative Diseases and the Potential Strategy for the Therapeutics

2023-06-29

Abstract excerpt

Changes in epitranscriptome with N6‐methyladenine (m6A) modification could be involved in the development of multiple diseases, which might be a prevalent modification of messenger RNAs (mRNAs) in eukaryotes. The m6A modification might be performed through the action of methyltransferases, demethylases, and methylation-binding proteins. Importantly, the m6A methylation may be associated with various neurological d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8fc8099f-ccd2-5026-9f74-8e56ba6577c9
DOI: 10.20944/preprints202306.2060.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Epitranscriptome Changes in Neurodegenerative Diseases and the Potential Strategy for the TherapeuticsDOI 10.20944/preprints202306.2060.v1Read

Dynamics of N6-methyladenosine modification during Alzheimer's disease developmentSemantic proximity Read

RNA methylation modifications in neurodegenerative diseases: Focus on their enzyme systemSemantic proximity Read

The m6A RNA methylation exerts a neuroprotective function by regulating the expression of α-synucleinSemantic proximity Read

Reduced levels of N6-methyladenosine in RNA of peripheral blood mononuclear cells from patients with Alzheimer's diseaseSemantic proximity Read

m 6 A RNA Modification Determines Cell Fate by Regulating mRNA DegradationSemantic proximity Read

The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseasesSemantic proximity Read

The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitusSemantic proximity Read

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.Semantic proximity Read

The regulatory role of m6A modification in the maintenance and differentiation of embryonic stem cellsSemantic proximity Read

Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.Semantic proximity Read

Loss of age-associated increase in m <sup>6</sup> A-modified RNA contributes to GABAergic dysregulation in Alzheimer’s diseaseSemantic proximity Read

Circadian rhythm in neurodegenerative disease: the role of RNA modifications and potential application of RNA-based therapeuticsSemantic proximity Read